Delivery Order SPE2DB22D3016-SPE2DB24FBHG9
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,226.81, is for the supply of 4568059545 MYDAYIS ER 12.5 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.84 firm fixed-price contract is for the supply of MYDAYIS ER 12.5 MG CAPSULE 100S, with a completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,674.40 firm fixed-price contract is for the delivery of 4565453589 MYDAYIS ER 50 MG capsules in 100-count packages. The delivery order has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. This award is a part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,123.72 Firm Fixed Price Delivery Order (SPE2DX15D1053|SPE2DX24F6PQH) is for the supply of MYDAYIS ER 12.5 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of July 2, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,975.53, is a delivery order for the supply of 100 units of the drug MYDAYIS ER 50 MG CAPSULE. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of pharmaceutical products, specifically MYDAYIS ER 37.5 MG CAPSULE 100S, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,971.74 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of MYDAYIS ER 25 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,087.34 firm fixed price delivery order has a completion date of July 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,087.34 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract covers the provision of MYDAYIS ER 25 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through October 28, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the prescription drug MYDAYIS CAPS 50MG, with a ceiling value of $4,528.91 and a performance period ending on April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,916.02, is for the delivery of 4567873454 - DEXTROAMP-AMPHET ER 30 MG CAP 100S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...